摘要
目前,皮肤癌被认为是人类普遍存在的恶性肿瘤。在不同的人群类型中,由于缺乏皮肤色素沉着,与深色皮肤人群相比,高加索人群更容易患这种恶性肿瘤。皮肤癌分为恶性和非黑色素瘤皮肤癌,进一步分为基底细胞癌和鳞状细胞癌。暴露于紫外线辐射、化学致癌物(多环芳烃、砷、焦油等)和病毒(疱疹病毒、人乳头瘤病毒和 1 型人 T 细胞白血病病毒)是导致皮肤癌的主要因素。有不同的途径可用于皮肤癌的发展,例如 JAK-STAT 途径、Akt 途径、MAPKs 信号通路、Wnt 信号通路等等。目前,有几种靶向治疗可用,例如单克隆抗体,它们极大地改变了这种疾病的治疗方法,但具有主要的治疗局限性。因此,许多植物化学物质已被单独评估或与现有合成药物联合评估以克服其局限性,并被发现在预防和治疗中发挥有希望的作用。在这篇综述中,对皮肤癌的完整概述,从所涉及的信号通路、新开发的药物及其靶点和局限性,以及天然产物单独或组合作为强效抗癌剂的新兴作用及其所涉及的分子机制已经讨论过。除此之外,这里还提到了各种纳米货物,它们可以在不同类型的皮肤癌的管理和治疗中发挥重要作用。
关键词: 黑色素瘤、Wnt 信号通路、单克隆抗体、hedgehog 通路抑制剂、植物治疗剂、脂质纳米货物。
Current Medicinal Chemistry
Title:Targeted Delivery of Natural Bioactives and Lipid-nanocargos against Signaling Pathways Involved in Skin Cancer
Volume: 28 Issue: 39
关键词: 黑色素瘤、Wnt 信号通路、单克隆抗体、hedgehog 通路抑制剂、植物治疗剂、脂质纳米货物。
摘要: At present, skin cancer is considered a widespread malignancy in human beings. Among diverse population types, Caucasian populations are much more prone to this malignancy in comparison to darker skin populations due to the lack of skin pigmentation. Skin cancer is divided into malignant and non-melanoma skin cancer, which is further categorized as basal and squamous cell carcinoma. Exposure to ultraviolet radiation, chemical carcinogen (polycyclic aromatic hydrocarbons, arsenic, tar, etc.), and viruses (herpes virus, human papillomavirus, and human T-cell leukemia virus type-1) are major contributing factors to skin cancer. There are distinct pathways available through which skin cancer develops, such as the JAK-STAT pathway, Akt pathway, MAPKs signaling pathway, Wnt signaling pathway, to name a few. Currently, several targeted treatments are available, such as monoclonal antibodies, which have dramatically changed the line of treatment of this disease but possess major therapeutic limitations. Thus, many phytochemicals have been evaluated either alone or in combination with the existing synthetic drugs to overcome their limitations and have been found to play a promising role in the prevention and treatment. In this review, a complete overview of skin cancer, starting from the signaling pathways involved, newer developed drugs with their targets and limitations, along with the emerging role of natural products alone or in combination as potent anticancer agents and their molecular mechanism involved has been discussed. Apart from this, various nano-cargos have also been mentioned here, which can play a significant role in the management and treatment of different types of skin cancer.
Export Options
About this article
Cite this article as:
Targeted Delivery of Natural Bioactives and Lipid-nanocargos against Signaling Pathways Involved in Skin Cancer, Current Medicinal Chemistry 2021; 28 (39) . https://dx.doi.org/10.2174/0929867327666201104151752
DOI https://dx.doi.org/10.2174/0929867327666201104151752 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pulmonary Manifestations of Rheumatoid Arthritis, Psoriatic Arthritis and Peripheral Spondyloarthritis: Prevalence, Diagnostic Approach and Treatment Options
Current Rheumatology Reviews Improvement of Nonviral Gene Therapy by Epstein-Barr Virus (EBV)-based Plasmid Vectors
Current Gene Therapy Role of Mitochondrial Translocator Protein (18 kDa) on Mitochondrial- Related Cell Death Processes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Gadd45 Proteins as Critical Signal Transducers Linking NF-κB to MAPK Cascades
Current Cancer Drug Targets Nano Drug Delivery in Treatment of Oral Cancer, A Review of the Literature
Current Drug Targets Counter-Regulatory Role of Bile Acid Activated Receptors in Immunity and Inflammation
Current Molecular Medicine Minireview: Peptide Analogs and Short Sequence Oligopeptides as Modulators of Skin Pigmentation
Current Topics in Medicinal Chemistry Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma
Current Molecular Medicine Prospective Teratology of Retinoic Acid Metabolic Blocking Agents (RAMBAs) and Loss of CYP26 Activity
Current Pharmaceutical Design Plant Proteomics Databases: Their Status in 2005
Current Bioinformatics Role of NF-κB and NF-κB-regulated Gene Products in Chemoresistance and Radioresistance
Current Cancer Therapy Reviews Renin-Angiotensin-Aldosterone System: A Current Drug Target for the Management of Neuropathic Pain
Current Drug Targets Histone Modifications, Stem Cells and Prostate Cancer
Current Pharmaceutical Design Current Concepts in Gastric Motility in Diabetes Mellitus
Current Diabetes Reviews Mouse Strains for Prostate Tumorigenesis Based on Genes Altered in Human Prostate Cancer
Current Drug Targets Immunomics in Skin Cancer - Improvement in Diagnosis, Prognosis and Therapy Monitoring
Current Proteomics Traditional Chinese Medicines (TCMs) for Molecular Targeted Therapies of Tumours
Current Drug Discovery Technologies Green Tea Catechins as Novel Antitumor and Antiangiogenic Compounds
Current Medicinal Chemistry - Anti-Cancer Agents Equilibrative Nucleoside (ENTs) and Cationic Amino Acid (CATs) Transporters: Implications in Foetal Endothelial Dysfunction in Human Pregnancy Diseases
Current Vascular Pharmacology Bioinformatics Tools for Mass Spectrometry-Based High-Throughput Quantitative Proteomics Platforms
Current Proteomics